A stress-induced early innate response causes multidrug tolerance in melanoma-Reference-Cited by-同舟云学术

A stress-induced early innate response causes multidrug tolerance in melanoma

Published:2014-11-24 Issue:34 Volume:34 Page:4448-4459
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Ravindran Menon D,Das S,Krepler C,Vultur A^ORCID,Rinner B,Schauer S,Kashofer K,Wagner K,Zhang G,Bonyadi Rad E,Haass N K,Soyer H P,Gabrielli B,Somasundaram R,Hoefler G,Herlyn M,Schaider H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

http://www.nature.com/articles/onc2014372.pdf

Reference34 articles.

1. Flaherty KT, Infante JR, Daud A, Gonzalez R, Kefford RF, Sosman J et al. Combined BRAF and MEK inhibition in melanoma with BRAF V600 mutations. N Engl J Med 2012; 367: 1694–1703.

2. Nazarian R, Shi H, Wang Q, Kong X, Koya RC, Lee H et al. Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation. Nature 2010; 468: 973–977.

3. Das TM, Salangsang F, Landman AS, Sellers WR, Pryer NK, Levesque MP et al. Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature 2013; 494: 251–255.

4. Sharma SV, Lee DY, Li B, Quinlan MP, Takahashi F, Maheswaran S et al. A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell 2010; 141: 69–80.

5. Roesch A, Fukunaga-Kalabis M, Schmidt EC, Zabierowski SE, Brafford PA, Vultur A et al. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth. Cell 2010; 141: 583–594.

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia;Biological Research;2024-09-03

2. Cancer drug-tolerant persister cells: from biological questions to clinical opportunities;Nature Reviews Cancer;2024-09-02

3. Cyclic tachyplesin I kills proliferative, non-proliferative and drug-resistant melanoma cells without inducing resistance;Pharmacological Research;2024-09

4. Drug resistance in human cancers — Mechanisms and implications;Life Sciences;2024-09

5. Targeting TREX1 Induces Innate Immune Response in Drug-Resistant Small-Cell Lung Cancer;Cancer Research Communications;2024-09-01